Back to Search
MURAT ARCASOY, MD
MD
Hematology & Oncology Physician
NPI: 1760420145Individual
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
99-01501(NC)
Research & Publications (20)
Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectives.
PMID 18676735·Clin Cancer Res·2008
6-review
The non-haematopoietic biological effects of erythropoietin.
PMID 18324962·Br J Haematol·2008
6-review
Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor.
PMID 15982354·Br J Haematol·2005
8-other
Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
PMID 15878737·Biochim Biophys Acta·2005
7-preclinical
Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia.
PMID 15671524·Clin Cancer Res·2005
8-other
Erythropoietin and erythropoietin receptor expression in human prostate cancer.
PMID 15467711·Mod Pathol·2005
4-observational
Expression of erythropoietin receptor splice variants in human cancer.
PMID 12878211·Biochem Biophys Res Commun·2003
7-preclinical
Functional significance of erythropoietin receptor expression in breast cancer.
PMID 12118093·Lab Invest·2002
7-preclinical
A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis.
PMID 11929803·Blood·2002
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- DUKE UNIVERSITY MEDICAL CENTER, BOX 3912 DUMC
DURHAM, NC 27710 - Phone
- (919) 668-6309
Quick Facts
- NPI
- 1760420145
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile